[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Unterman et al., 2022 - Google Patents

Single-cell multi-omics reveals dyssynchrony of the innate and adaptive immune system in progressive COVID-19

Unterman et al., 2022

View HTML @Full View
Document ID
6360894800718017789
Author
Unterman A
Sumida T
Nouri N
Yan X
Zhao A
Gasque V
Schupp J
Asashima H
Liu Y
Cosme Jr C
Deng W
Chen M
Raredon M
Hoehn K
Wang G
Wang Z
DeIuliis G
Ravindra N
Li N
Castaldi C
Wong P
Fournier J
Bermejo S
Sharma L
Casanovas-Massana A
Vogels C
Wyllie A
Grubaugh N
Melillo A
Meng H
Stein Y
Minasyan M
Mohanty S
Ruff W
Cohen I
Raddassi K
Yale IMPACT Research Team Nelson Allison 10 Shepard Denise 21 Rainone Michael 1 Peng Xiaohua 1
Niklason L
Ko A
Montgomery R
Farhadian S
Iwasaki A
Shaw A
van Dijk D
Zhao H
Kleinstein S
Hafler D
Kaminski N
Dela Cruz C
Publication year
Publication venue
Nature communications

External Links

Snippet

Dysregulated immune responses against the SARS-CoV-2 virus are instrumental in severe COVID-19. However, the immune signatures associated with immunopathology are poorly understood. Here we use multi-omics single-cell analysis to probe the dynamic immune …
Continue reading at www.nature.com (HTML) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5047—Cells of the immune system
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Hybridisation probes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING; COUNTING
    • G06F—ELECTRICAL DIGITAL DATA PROCESSING
    • G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
    • G06F19/10—Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology

Similar Documents

Publication Publication Date Title
Unterman et al. Single-cell multi-omics reveals dyssynchrony of the innate and adaptive immune system in progressive COVID-19
Ramaswamy et al. Immune dysregulation and autoreactivity correlate with disease severity in SARS-CoV-2-associated multisystem inflammatory syndrome in children
Marin et al. Safety, efficacy and determinants of response of allogeneic CD19-specific CAR-NK cells in CD19+ B cell tumors: a phase 1/2 trial
Falck-Jones et al. Functional monocytic myeloid-derived suppressor cells increase in blood but not airways and predict COVID-19 severity
Hashimoto et al. PD-1 combination therapy with IL-2 modifies CD8+ T cell exhaustion program
Moreews et al. Polyclonal expansion of TCR Vβ 21.3+ CD4+ and CD8+ T cells is a hallmark of multisystem inflammatory syndrome in children
Peng et al. An immunodominant NP105–113-B* 07: 02 cytotoxic T cell response controls viral replication and is associated with less severe COVID-19 disease
Hoste et al. TIM3+ TRBV11-2 T cells and IFNγ signature in patrolling monocytes and CD16+ NK cells delineate MIS-C
Stephenson et al. Single-cell multi-omics analysis of the immune response in COVID-19
Tian et al. Single-cell immunology of SARS-CoV-2 infection
US20240264151A1 (en) Methods and Compositions for Treating Diseases Associated with Exhausted T Cells
He et al. Follicular CXCR5-expressing CD8+ T cells curtail chronic viral infection
Sparks et al. Influenza vaccination reveals sex dimorphic imprints of prior mild COVID-19
Cerosaletti et al. Single-cell RNA sequencing reveals expanded clones of islet antigen-reactive CD4+ T cells in peripheral blood of subjects with type 1 diabetes
Tippalagama et al. HLA-DR marks recently divided antigen-specific effector CD4 T cells in active tuberculosis patients
Ayano et al. Increased CD226 expression on CD8+ T cells is associated with upregulated cytokine production and endothelial cell injury in patients with systemic sclerosis
Silverstein et al. Innate lymphoid cells and COVID-19 severity in SARS-CoV-2 infection
Fischer et al. Single-cell RNA sequencing reveals ex vivo signatures of SARS-CoV-2-reactive T cells through ‘reverse phenotyping’
Yao et al. Single-cell transcriptome profiling of the immune space-time landscape reveals dendritic cell regulatory program in polymicrobial sepsis
Lareau et al. Latent human herpesvirus 6 is reactivated in CAR T cells
Ramaswamy et al. Post-infectious inflammatory disease in MIS-C features elevated cytotoxicity signatures and autoreactivity that correlates with severity
Eddins et al. Transcriptional reprogramming of infiltrating neutrophils drives lung pathology in severe COVID-19 despite low viral load
van Schaik et al. Discovery of invariant T cells by next-generation sequencing of the human TCR α-chain repertoire
Stephenson et al. The cellular immune response to COVID-19 deciphered by single cell multi-omics across three UK centres
Liu et al. Single-cell analysis reveals macrophage-driven T cell dysfunction in severe COVID-19 patients